LTF and COVID-19: A similar study found that oral and intranasal treatment of mild‐to‐moderate and asymptomatic COVID‐19 patients with liposomal bovine lactoferrin significantly reduced the mean time length of rRT‐PCR SARS‐COV‐2 RNA‐negative conversion in comparison with the standard‐of‐care (SOC)‐treated and nontreated patients (Campione et al., 2020).